Vital Art and Science, Inc.

Vital Art and Science, Inc. develops innovative healthcare solutions focused on vision monitoring, utilizing technology to assist patients and providers in managing macular diseases effectively. Founded in 2006, Vital Art and Science, Inc. is based in Richardson, US.

The company specializes in providing digital health solutions for vision impairments, with its flagship product being the myVisionTrack platform. The founders, Bobbie Valdez and Mike Bartlett, aimed to enhance patient care through technology. In August 2013, the company raised USD 0. 55 mn in a Series A funding round from North Texas Angel, bringing the total amount raised to USD 0.

55 mn and establishing a company valuation of USD 10. 00 mn. The primary offering of Vital Art and Science, Inc. is the myVisionTrack platform, comprising a mobile app for at-home vision monitoring of patients experiencing macular diseases and a healthcare provider portal for essential patient data management.

This service enhances communication between healthcare providers and patients, facilitating timely interventions for visual health declines. The app alerts users about their vision test results, while the portal allows healthcare professionals to track patient progress. The company's customers include healthcare providers and individuals diagnosed with macular diseases, primarily in North America, Europe, and parts of Asia. Vital Art and Science, Inc.

generates revenue through a subscription-based model for its myVisionTrack services, which includes both the mobile app and provider portal. Providers pay for access to the platform, enabling effective patient management and monitoring. This structure fosters direct relationships with healthcare providers and potentially facilitates partnerships with clinics and hospitals. The pricing plans are designed to enhance accessibility for healthcare providers while ensuring the service's sustainability.

Vital Art and Science, Inc. intends to leverage recent funding from the August 2013 Series A round to further develop the myVisionTrack platform, with plans for new product enhancements and features aimed at improving user experience. The company is also exploring opportunities to expand its reach into untapped markets in Europe and Asia, with the goal of establishing a stronger presence by 2025. The focus will be on tailoring their services to meet the specific needs of healthcare providers in these regions, improving access to vision care solutions.